NIM
DGX icon

NEOS Investment Management’s Quest Diagnostics DGX Stock Holding History

NEOS Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.65M Buy
17,210
+2,099
+14% +$412K 0.01% 421
2026
Q1 		$2.96M Buy
15,111
+12,749
+540% +$2.48M 0.02% 426
2025
Q4 		$410K Buy
2,362
+11
+0.5% +$2K ﹤0.01% 621
2025
Q3 		$448K Buy
+2,351
New +$417K ﹤0.01% 583

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

NEOS Investment Management's DGX Position: Q2 2026 in Review

NEOS Investment Management increased its Quest Diagnostics (DGX) stake by 14% in Q2 2026, buying an estimated $412K and bringing the position to 17,210 shares worth $3.65M. The position accounts for 0.01% of the portfolio, ranked #421.

NEOS Investment Management first reported a position in DGX in Q3 2025 and has held it in 4 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • NEOS Investment Management held 17,210 shares of Quest Diagnostics worth $3.65M as of Q2 2026.
  • NEOS Investment Management bought 2,099 Quest Diagnostics shares in Q2 2026, an estimated $412K.
  • Quest Diagnostics made up 0.01% of NEOS Investment Management's portfolio in Q2 2026, its #421 holding.
  • NEOS Investment Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 4 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.